tradingkey.logo

TELA Bio Inc <TELA.OQ> expected to post a loss of 22 cents a share - Earnings Preview

ReutersMar 18, 2025 8:26 PM
  • TELA Bio Inc TELA.OQ TELA.O is expected to show a rise in quarterly revenue when it reports results on March 20 for the period ending December 31 2024

  • The Malvern Pennsylvania-based company is expected to report a 36.3% increase in revenue to $23.166 million from $17 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for TELA Bio Inc is for a loss of 22 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for TELA Bio Inc is $9.00​, above​ its last closing price of $2.43. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.42

-0.40

-0.42

Missed

-3.9

Jun. 30 2024

-0.46

-0.47

-0.51

Missed

-8.1

Mar. 31 2024

-0.51

-0.50

-0.23

Beat

54.1​

Dec. 31 2023

-0.42

-0.43

-0.53

Missed

-21.9

​​Sep. 30 2023

-0.49

-0.49

-0.45

Beat

8.5

Jun. 30 2023

-0.53

-0.53

-0.46

Beat

13.7​

Mar. 31 2023

-0.56

-0.56

-0.63

Missed

-12.7

Dec. 31 2022

-0.51

-0.55

-0.52

Beat

4.8

This summary was machine generated March 18 at 20:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI